Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | 0.67% | 345.22 | 1.2% | $624.02m | |
| GILD | Gilead Sciences, Inc. | -3.53% | 72.92 | 0.9% | $510.71m | |
| CELG | Celgene Corporation | 0.24% | 90.37 | 1.2% | $496.41m | |
| AMGN | Amgen Inc. | 0.50% | 197.42 | 1.2% | $485.34m | |
| ILMN | Illumina, Inc. | -0.34% | 325.88 | 3.5% | $373.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.67% | 374.26 | 2.6% | $315.78m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.64% | 176.08 | 1.9% | $209.08m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.09% | 116.00 | 2.0% | $186.59m | |
| A | Agilent Technologies, Inc. | -1.28% | 64.66 | 1.5% | $159.27m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.52% | 130.25 | 16.6% | $142.46m | |
| NKTR | Nektar Therapeutics | 0.13% | 60.03 | 5.6% | $126.29m | |
| BLUE | Bluebird Bio, Inc. | 1.15% | 158.00 | 14.6% | $121.57m | |
| EXAS | Exact Sciences Corporation | 0.33% | 48.84 | 25.3% | $118.82m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.69% | 101.01 | 4.4% | $118.74m | |
| INCY | Incyte Corporation | 1.40% | 68.80 | 2.5% | $111.73m |
Company Profile
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.